Despite PLBY Group's falling revenue, its P/S ratio aligns with industry peers, hinting at investor hopes for a business revival. However, with a negative revenue growth forecast, current price levels may be unsustainable, risking further share price decline.
Investors anticipate a positive change in the firm's business outlook despite analysts' doubts. The current P/S ratio doesn't support a positive sentiment considering the expected revenue decline.
Merck & Co ($默沙東(MRK.US)$) EPS of $1.62 vs $1.54 estimate Revenue of $13.80B vs $13.67B Sony ($索尼(SONY.US)$) EPS of $1.86 vs $1.37 estimate Revenue of $24.09B vs $24.52B estimate Eli Lilly ($禮來(LLY.US)$) EPS of $2.09 vs $1.78 estimate Revenue of $7.30B vs $7.33B estimate ConocoPhilips ($康菲石油(COP.US)$) EPS of $2.71 vs $2.81 estimate Revenue of $19.26B vs $18.03B estimate Alphabet ($谷歌-A(GOOGL.US)$) EPS of ...
PLBY Group股票討論區
Most Important Stock Market News from Today
EPS of $1.62 vs $1.54 estimate
Revenue of $13.80B vs $13.67B
Sony ( $索尼(SONY.US)$ )
EPS of $1.86 vs $1.37 estimate
Revenue of $24.09B vs $24.52B estimate
Eli Lilly ( $禮來(LLY.US)$ )
EPS of $2.09 vs $1.78 estimate
Revenue of $7.30B vs $7.33B estimate
ConocoPhilips ( $康菲石油(COP.US)$ )
EPS of $2.71 vs $2.81 estimate
Revenue of $19.26B vs $18.03B estimate
Alphabet ( $谷歌-A(GOOGL.US)$ )
EPS of ...
Worth long term hold
暫無評論